SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-028495
Filing Date
2015-05-07
Accepted
2015-05-07 17:28:58
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v408229_10q.htm 10-Q 429962
2 EXHIBIT 31.1 v408229_ex31-1.htm EX-31.1 8947
3 EXHIBIT 31.2 v408229_ex31-2.htm EX-31.2 8635
4 EXHIBIT 32.1 v408229_ex32-1.htm EX-32.1 4068
5 EXHIBIT 32.2 v408229_ex32-2.htm EX-32.2 3909
  Complete submission text file 0001144204-15-028495.txt   4853491

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20150331.xml EX-101.INS 728811
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20150331.xsd EX-101.SCH 34882
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20150331_cal.xml EX-101.CAL 38116
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20150331_def.xml EX-101.DEF 215691
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20150331_lab.xml EX-101.LAB 319248
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20150331_pre.xml EX-101.PRE 266134
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 15843172
SIC: 2836 Biological Products, (No Diagnostic Substances)